Allergic diseases

Last decades are marked by a significant rise of allergic  diseases, such as bronchial asthma, allergic rhinitis, hives, angioedema and atopic dermatitis. In Russia incidence of bronchial asthma of  severity is diagnosed  in 4 to 10% of population. Currently in the development is a  highly effective biosimilar agent for the treatment of moderate to severe persistent asthma whose symptoms are not controlledby conventional therapy .  

Our products:

GNR-044 Protein based Biosimilar R&D stage